Trytosaveabit commented on a stock · Jan 3 06:20

Update

$Apollomics(APLM.US)$ Apollomics Completes Enrollment In Phase 3 Bridging Study Of Uproleselan (APL-106) Added To A Standard Chemotherapy Regimen In Chinese Patients With Relapsed/Refractory Acute Myeloid Leukemia
Benzinga· 3 mins ago

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

4307 Views

Comment

Trytosaveabit

1841Followers

30Following

22KVisitors